-
Company Insights
NewBone Biologics Corp Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Bone Biologics Corp Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Bone Biologics Corp (Bone Biologics) is a biotechnology company which develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers NELL-1/DBX fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate...
-
Product Insights
NewRegeneron Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Regeneron Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Regeneron Pharmaceuticals Inc (Regeneron) is engaged in discovering, developing, manufacturing, and marketing medicines for the treatment of serious medical conditions. Its products are focused on helping patients suffering from cancer, allergic and inflammatory diseases, eye diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, hematologic conditions, pain, and rare diseases. It develops products using its Trap and VelociSuite technology...
-
Product Insights
Innovations in Personalized Medicine (AI/ML Based) – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Personalized Medicine (AI/ML Based) - Global Pipeline Summary" provides comprehensive information about the Personalized Medicine (AI/ML Based) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Personalized Medicine (AI/ML Based) report provides key information and data related to: Extensive coverage of the Personalized Medicine (AI/ML Based) under development Review details of major pipeline products which include product description, licensing and collaboration...
-
Product Insights
Landeskliniken – Internal Medicine III Healthcare Building – Salzburg
The Landeskliniken – Internal Medicine III Healthcare Building – Salzburg involves the construction of the Internal Medicine III House L building in Salzburg, Austria. Equip yourself with the essential tools needed to make informed and profitable decisions with our Landeskliniken – Internal Medicine III Healthcare Building – Salzburg report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
Image Guided Surgery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Image Guided Surgery Pipeline Market Report Overview Image Guided Surgery devices use real-time images during surgery to assist surgeons in precisely guiding the surgical instruments to the anatomic structures. It helps minimize the chances of errors and reduce the procedure time. The Image Guided Surgery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...
-
Product Insights
Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cu(II)ATSM in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cu(II)ATSM in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cu(II)ATSM in Parkinson's Disease Drug Details: Cu(II)ATSM is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cu(II)ATSM in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cu(II)ATSM in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cu(II)ATSM in Amyotrophic Lateral Sclerosis Drug Details: Cu(II)ATSM is under development...
-
Product Insights
NewEbolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain, and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids, and pain relievers. The Ebolavirus Infections (Ebola Hemorrhagic Fever) drugs in development market...
-
Product Insights
NewFrontotemporal Dementia (FTD) – Drugs In Development, 2024
Empower your strategies with our Frontotemporal Dementia (FTD) – Drugs In Development, 2024 report and make more profitable business decisions. Frontotemporal dementia (FTD) encompasses various brain disorders leading to progressive damage in the frontal and temporal lobes. It manifests in distinct ways: behavioral changes, language difficulties, or movement impairments. Symptoms range from altered social conduct, lack of empathy, and impulsivity to language struggles or motor coordination issues. FTD's exact cause remains unclear, but abnormal protein deposits in the brain are implicated....